Dr Lizette Louw explains how peptide receptor radionuclide therapy using Lutetium-177 radiation targets neuroendocrine tumours.
You can listen to this article below, or by using your favourite podcast player at pod.link/oncologybuddies
Dr Lizette Louw explains how peptide receptor radionuclide therapy using Lutetium-177 radiation targets neuroendocrine tumours.
You can listen to this article below, or by using your favourite podcast player at pod.link/oncologybuddies